Software Healthcare Sector

Solana

Market Cap: US$127.0m

Operates as a listed digital asset treasury.

Nakamoto

Market Cap: US$126.3m

Develops and invests in a global portfolio of Bitcoin-native companies.

Anixa Biosciences

Market Cap: US$126.2m

A biotechnology company, develops therapies and vaccines that are focused on critical unmet needs in oncology.

Faron Pharmaceuticals Oy

Market Cap: UK£92.0m

Operates as a clinical stage drug discovery and development company.

Vaxart

Market Cap: US$125.1m

A clinical-stage biotechnology company, discovers and develops oral recombinant protein vaccines based on its vector-adjuvant-antigen standardized technology proprietary oral vaccine platform.

Bioventix

Market Cap: UK£91.4m

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide.

Vivani Medical

Market Cap: US$124.5m

A clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases.

Fractyl Health

Market Cap: US$124.2m

A metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity.

Rani Therapeutics Holdings

Market Cap: US$122.7m

Operates as a clinical stage biotherapeutics company, focusing on technologies to enable the administration of biologics and drugs orally for patients, physicians, and healthcare systems with a alternative to painful injections in the United States.

Inovio Pharmaceuticals

Market Cap: US$122.0m

A biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases.

Genelux

Market Cap: US$121.9m

A clinical-stage biopharmaceutical company, focuses on developing oncolytic viral immunotherapies for patients suffering from aggressive and/or difficult-to-treat solid tumor types.

Nautilus Biotechnology

Market Cap: US$121.5m

A development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the proteome in the United States.

EMVision Medical Devices

Market Cap: AU$167.3m

Engages in the research, development, and commercialization of neurodiagnostic technology for stroke diagnosis and monitoring, and other medical imaging needs in Australia.

enGene Therapeutics

Market Cap: US$119.2m

Through its subsidiary enGene, Inc., operates as a clinical-stage biotechnology company in Canada.

Grown Rogue International

Market Cap: CA$165.0m

Through its subsidiaries, engages in cultivation, manufacture, possession, sale, and distribution of marijuana in the United States.

Scientist Home Future Health

Market Cap: US$118.6m

Engages in the retail trading of health supplements and topical creams in Hong Kong and internationally.

Axe Compute

Market Cap: US$118.3m

Provides access to graphics processing unit and digital asset treasury strategy.

Medexus Pharmaceuticals

Market Cap: CA$161.9m

Operates as a pharmaceutical company in Canada and the United States.

NeOnc Technologies Holdings

Market Cap: US$116.2m

A clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies.

Health Catalyst

Market Cap: US$115.1m

Provides data and analytics technology and services to healthcare organizations in the United States.

Joint

Market Cap: US$114.8m

Operates and is a franchisor and operator of chiropractic clinics in the United States.

Cumberland Pharmaceuticals

Market Cap: US$114.6m

A specialty pharmaceutical company, focuses on the acquisition, development, and commercialization of prescription products.

Coya Therapeutics

Market Cap: US$114.2m

A clinical-stage biotechnology company, engages in the development of proprietary therapies to enhance the function of regulatory T cells (Tregs).

Vita Life Sciences

Market Cap: AU$157.3m

A healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China.

Actinogen Medical

Market Cap: AU$157.3m

A biotechnology company, develops therapies for neurological and neuropsychiatric diseases associated with dysregulated brain cortisol in Australia.

Seer

Market Cap: US$112.4m

A life sciences company, develops and commercializes products to decode the biology of the proteome to improve human health in the United States, China, Australia, Europe, Israel, Japan, and South Africa.

Rafael Holdings

Market Cap: US$112.3m

Primarily engages in holding interests in clinical and early-stage pharmaceutical companies, and medical devices in the United States and Israel.

Saluda Medical

Market Cap: AU$153.7m

A medical device company, develops Evoke, an investigational device for the neuromodulation industry in the United States, Australia, the United Kingdom, and the Netherlands.

Quantum Cyber

Market Cap: US$109.3m

Operates as a technology company focused on cybersecurity and quantum computing solutions.

Burning Rock Biotech

Market Cap: US$108.8m

Develops and sells cancer therapy selection tests in the People's Republic of China and the United States.

Helix BioPharma

Market Cap: CA$150.5m

A clinical-stage biopharmaceutical company developing therapies in the field of immune-oncology in Canada.

Oncolytics Biotech

Market Cap: US$107.5m

A clinical-stage biopharmaceutical company, engages in the research, development, and commercialization of oncology treatments.

CareCloud

Market Cap: US$106.7m

A healthcare information technology company, provides technology-enabled business solutions, Software-as-a-Service offerings, and related business services to healthcare providers and hospitals primarily in the United States.

LENSAR

Market Cap: US$106.6m

A commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally.

Kewaunee Scientific

Market Cap: US$106.3m

Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products in the United States and internationally.

Development Technologies

Market Cap: US$105.2m

Manufactures and provides an advanced ECG system for the non-invasive screening of heart pathologies.